101 results
Page 5 of 6
8-K
EX-99.1
c060zfg enu
14 Nov 18
Avenue Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
4:31pm
8-K
EX-10.9
rj01ylnwqt97 mr98p
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
8-K
EX-10.1
klqnt9zhox8
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
8-K
EX-10.7
bgaebuxud84j
14 Nov 18
Entry into a Material Definitive Agreement
12:53pm
8-K
EX-99.1
n7fq8alt
14 Aug 18
Avenue Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
9:00am
8-K
EX-99.1
jlzu cyu8
25 May 18
Regulation FD Disclosure
8:30am
8-K
EX-99.1
8u2h8irab400au ecbtr
21 May 18
Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative Pain
8:15am
8-K
EX-99.1
t0fepzs3 hu
3 May 18
Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
8:00am
DEF 14A
4w14 xlei41
30 Apr 18
Definitive proxy
7:02am
10-K
jyd1f86m
1 Mar 18
Annual report
12:00am
8-K
EX-99.1
abmvz
14 Jul 17
Other Events
12:00am
10-Q
t4ag6pcg
12 May 17
Quarterly report
12:00am
10-12G/A
hkpgn7uvn
13 Mar 17
Registration of securities (amended)
12:00am
10-12G/A
4vo0uw8nhsz0cgblwjs
6 Mar 17
Registration of securities (amended)
12:00am
10-12G
9otp 03qc
12 Jan 17
Registration of securities
12:00am
10-12G/A
45hu03s0
18 Feb 16
Registration of securities (amended)
12:00am